SGMT vs VNDA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SGMT Captures Institutional Edge (3โ1 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sagimet Biosciences Inc. Series A Common Stock (SGMT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while VNDA counters with relative strength in Valuation. Fundamentally, SGMT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VNDA at 103.1x Forward P/E and -77.6% operating margin (+24.1% YoY). In options structure, SGMT sits in BREAKOUT (5th %ile IV; Dealer Gamma Walls on Pro) against VNDA sits in BREAKDOWN (75th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SGMT Revenue | VNDA Revenue | SGMT Op. Margin | VNDA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $190M | N/A | 11.3% | VNDA |
| FY2019 | N/A | $230M | N/A | 10.0% | VNDA |
| FY2020 | N/A | $250M | N/A | 11.0% | VNDA |
| FY2021 | N/A | $270M | N/A | 15.7% | VNDA |
| FY2022 | N/A | $250M | N/A | 2.5% | VNDA |
| FY2023 | $0M | $190M | -1537.0% | -7.2% | VNDA |
| FY2024 | N/A | $200M | N/A | -20.5% | VNDA |
| FY2025 | N/A | $220M | N/A | -70.0% | VNDA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SGMT | VNDA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $775.0M | $238.9M | Larger Scale | SGMT |
| Trailing P/E Ratio Valuation | N/M | 103.1x | Lower Multiple | VNDA |
| Forward P/E Ratio Valuation | N/M | 103.1x | Lower Multiple | VNDA |
| Revenue Growth (YoY) Growth | +0.0% | +24.1% | Higher Growth | VNDA |
| Operating Margin (TTM) Profitability | 0.0% | -77.6% | Higher Margin | SGMT |
| Net Profit Margin Profitability | 0.0% | -119.9% | Higher Margin | SGMT |
| Return on Equity (ROE) Capital Efficiency | -24.4% | -82.5% | Higher ROE | SGMT |
| 52-Week Range Position Momentum | 83% ($4โ$11) | 4% ($4โ$10) | Stronger Trend | SGMT |
| Beta / 30D Volatility Risk Regime | 2.05ฮฒ ยท 84% Vol | 1.25ฮฒ ยท 61% Vol | Lower Realized Risk | VNDA |
| Unified Institutional Score Composite Signal | 43.1 / 100 (HOLD) | 49.0 / 100 (HOLD) | Higher Composite | VNDA |